Rospotrebnadzor announced the benefits of pharmaceutical companies from discussing “disease X”

Rospotrebnadzor drew attention to the discussion on the sidelines of the second session of the National People’s Congress of China about the risks of the global spread of a new potential disease – “Disease X”. The agency notes that this topic is regularly raised in the information space and is “beneficial to large pharmaceutical companies.” Rospotrebnadzor claims that Russia is ready for new infectious challenges.

“Every year, “Disease X” is discussed by the scientific community at well-known forums, congresses and conferences. Thus, on the sidelines of the second session of the National People’s Congress of China, experts discussed the risks of the global spread of a new potentially unknown disease – “Disease X”. This topic regularly appears in the information space and is beneficial to large pharmaceutical companies, including due to the memory of the coronavirus pandemic,” it says message Rospotrebnadzor.

The Russian agency notes that the term “disease X” has existed for many years and implies “an abstract disease caused by an unknown pathogen.”

As the department notes, readiness for new infectious challenges in Russia “is at a high level.” The “Sanitary Shield” anti-infection system is in place, a network of PCR centers is being developed, rapid test systems have been developed, and sanitary and quarantine control and the “Perimeter” automated information system are in effect at the border. Rospotrebnadzor works with representatives of other countries to recognize and respond to emerging threats.

Russian Health Minister Mikhail Murashko in January statedthat “Disease X” is a hypothetical threat, but the Russian healthcare system of the Russian Federation is ready for it. In his opinion, one should always be prepared for more serious outbreaks of disease. The discussion about “Disease X” began in January with a discussion of the issue at the World Economic Forum in Davos.

Leonid Uvarchev